Study gives impetus to drive for effective malaria vaccine
- Details
- Category: Research
EU-funded researchers have demonstrated that it is possible to protect healthy volunteers against malaria by infecting them with malaria parasites while treating them with the antimalarial drug chloroquine. The findings, published in the New England Journal of Medicine (NEJM), raise hopes that it will soon be possible to develop an effective vaccine against the deadly disease.
Do You Know Which Pharmaceutical Product Sites are Tops Among Physicians in 2009?
- Details
- Category: Research
![Manhattan Research Manhattan Research](http://www.worldpharmanews.com/images/stories/logo/manhattanresearch.gif)
OpSec Security Identifies Alarming Trends in Illicit Bulk Pharmaceuticals and Drugs Online
- Details
- Category: Research
OpSec Security, Inc., the global leader in anti-counterfeiting and brand protection, today released a two-year study which shows substantial trends of increased illicit behavior by trade board sellers that offer bulk pharmaceuticals and active pharmaceutical ingredients (APIs) to buyers and intermediaries, and Internet pharmacies that sell drugs directly to consumers.
ONIX - New Online Portal for Cancer Researchers
- Details
- Category: Research
The National Cancer Research Institute's free online cancer research portal, ONIX, has launched to the public today. ONIX (ONcology Information eXchange) enables scientists and clinicians to search through and access international research data held online - to improve the flow of cancer research information between individuals, institutions and organisations.
DNA Electronics at the Forefront for Launch of UK Government "Life Sciences Blueprint"
- Details
- Category: Research
DNA Electronics Ltd, a developer of disposable, real-time gene testing at the point-of-care, has been showcased as an exemplary healthcare technology innovator at the launch of the Governmentâs Life Sciences Blueprint - a range of initiatives aimed at ensuring the UK remains a world-leading location to build and grow life science and biotechnology companies.
EU project tackles pain relief without the side effects
- Details
- Category: Research
The EU-funded SOS (Safety of non-steroidal anti-inflammatory drugs) project is working to provide medical professionals with guidance on the risks (both cardiovascular and gastrointestinal) associated with certain painkillers. Ultimately, the project results should help to better protect patients against these side effects. Non-steroidal anti-inflammatory drugs (NSAIDs) help reduce pain and inflammation, and are commonly given to sufferers of arthritis and other degenerative joint diseases.
Manhattan Research Report Explores Online Adherence Opportunities
- Details
- Category: Research
![Manhattan Research Manhattan Research](http://www.worldpharmanews.com/images/stories/logo/manhattanresearch.gif)
More Pharma News ...
- EU-funded study shows that cannabis can damage DNA
- New zebrafish model offers new insights into skin cancer
- Sharing the Sights of BioMedical and Pharmaceutical Domains on Demo-DVD
- More than Half of Rheumatoid Arthritis Patients Feel their Disease Controls their Lives
- Information Technology Award announced for pharmacy in 2010
- Regular aspirin use may do more harm than good, study warns
- From Pioneer to the World's Leading Scientific Network